The global Non-Invasive Prenatal Testing Market is anticipated to grow at 16.35% CAGR during the forecast period. Factors attributing to the growth of the Non-Invasive Prenatal Testing Market include the rising prominence of SSIs, rising number of surgical procedures, technological development of innovating new products, significant increase in the occurrence of complications from HAIs, and rising geriatric population. Nevertheless, the growing initiatives by government and rising number of collaborations by key industry players will create opportunities for growth of the Non-Invasive Prenatal Testing Market.
3M is on the mission to protect patients from preventable surgical site infections (SSIs) as they believe that up to 5% of patients undergoing surgery may have negative consequences of an SSI, as patients might have an increased length of stay in hospital that can impact the quality of life. So they are committed to using their best practices and evidence-based solutions to reduce the risk of SSIs in the facility
Request to get a free sample copy at https://www.vynzresearch.com/healthcare/non-invasive-prenatal-testing-market/request-sample
The COVID-19 outbreak has had a negative impact on Non-Invasive Prenatal Testing Market owing to decrease in funding of R&D activities associated with surgical site infection control agents and decrease in number of elective surgeries will adversely affect the market.
Based on product, the Non-Invasive Prenatal Testing Market is segmented into wound care dressings, antibiotic prophylaxis products, clippers, surgical drapes, antiseptics and disinfectants, surgical staff clothing, patient-warming products, wound irrigation products, wound care supplementary products and others. The antibiotic prophylaxis dominate the market owing to the increased cost of antibiotics, acceptance of antibiotics as most established preventive method for surgical site infections and patient friendly dosage forms like tablets, capsules, etc.
Asia-Pacific is expected to be the fastest-growing region in the Non-Invasive Prenatal Testing Market owing to increasing patient pool, increased awareness by government organizations, abd rising prominence of surgical site infections.
Some of the major players in the Non-Invasive Prenatal Testing Market include 3M Company, Medtronic plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Covalon Technologies Ltd., Stryker Corporation, Becton, Dickinson and Company, Prescient Surgical Inc., Surgical Site Infection Prevention LLC, and STERIS plc.
Source: VynZ Research